China Pharma Holdings (CPHI) Reports Q1 Loss of $0.18/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St declines as oil spikes after Trump rejects Iran peace proposal
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Bloom Energy shares fall on Oracle project halt
- Oppenheimer sees AI software winners as focus shifts to ROI
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
- Accenture (ACN) call put ratio 1 call to 1.2 puts into quarter results
China Pharma Holdings, Inc. Reports First Quarter 2015 Financial Results
May 12, 2015 6:00 AM EDTHAIKOU CITY, China, May 12, 2015 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma" or the "Company"), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended March 31, 2015.
First Quarter Highlights
Revenue decreased 20% to $5.7 million in the first quarter of 2015 from $7.1 million in the first quarter of 2014. Gross margin was 18.6% in the first  of quarter 2015, compared to 37.4% in the first quarter of 2014. Loss from operations was... More